I can now count myself as one of the few who has read the package insert for methotrexate. I am researching RA drugs for my book. I give myself injections of 25mg methotrexate weekly. I was opening a new box and preparing to give myself an injection. Impulsively, I decided to read the insert. Methotrexate has become the gold standard for RA treatment. It has been one of the few drugs to help relieve my symptoms. Imagine my surprise when I read the following.
Medication guide insert with boxed methotrexate; “Although methotrexate clearly ameliorates symptoms of inflammation (pain, swelling, stiffness), there is no evidence that it induces remission of rheumatoid arthritis nor has a beneficial effect been demonstrated on bone erosions and other radiologic changes which result in impaired joint use, functional disability, and deformity.”
So since it doesn’t stop RA progression how can it be classified as a DMARD, Disease Modifying Anti Rheumatic Drug? Shouldn’t it be a NSAID, Non-Steroidal Anti-Inflammatory Drug?